GHK-Cu vs TB-500: What Is the Difference?
Both turn up in tissue-repair research. One is a tiny molecule carrying a copper atom; the other is a piece of a protein found in nearly every cell.
In plain English
GHK-Cu is a very small peptide — three amino acids — holding a copper atom. It was identified in human blood in 1973, and researchers noticed its levels fall substantially as people age.
TB-500 is a laboratory-made piece of Thymosin Beta-4, a protein present in almost every cell in the body and especially concentrated in wound fluid.
The difference, without the jargon
They are studied in overlapping research areas through completely different mechanisms. GHK-Cu research centres on the building blocks of skin and connective tissue — collagen and the surrounding matrix — and copper itself plays a role there. TB-500 research centres on cell movement: it interacts with actin, the internal scaffolding that lets a cell change shape and travel, which matters when cells need to migrate into a damaged area. Day to day they are opposites in the vial. GHK-Cu is chemically particular — the wrong acidity or a common buffer additive will strip its copper away, and you can watch the blue colour fade when it happens. TB-500 has no such quirk but contains an amino acid that oxidises easily, so it wants darkness and minimal air exposure.
Common questions
What is the difference between GHK-Cu and TB-500?
GHK-Cu is a three-amino-acid molecule bound to copper, studied around collagen and skin-matrix research. TB-500 is a fragment of a much larger natural protein, studied around cell movement and tissue organisation. Different sizes, different mechanisms, overlapping research areas.
What does actin have to do with healing?
Actin is the internal scaffolding that lets cells change shape and move. Repair in a tissue model depends on cells being able to migrate to where they are needed, and TB-500 research examines its influence on that scaffolding.
Why does GHK-Cu need copper?
The copper is not an additive — it is part of the molecule. The research literature concerns the peptide-plus-copper unit, and the studied properties are attributed to that combination rather than to the peptide by itself.
Technical reference below
How they actually differ
Comparing the two: GHK-Cu is tripeptide-copper(ii) complex (gly-his-lys : cu²⁺), while TB-500 (Thymosin Beta-4) is synthetic fragment of thymosin beta-4 — different molecular classes with different handling consequences; they call for different primary diluents (sterile or bacteriostatic water versus bacteriostatic water (0.9% benzyl alcohol)); their leading degradation routes differ (copper dissociation at acidic ph for GHK-Cu, methionine sulfoxide formation for TB-500 (Thymosin Beta-4)), so the storage precautions that matter are not the same. The sections below set out each in full.
GHK-Cu — origin
GHK was identified by Loren Pickart in 1973 as a factor in human plasma whose concentration declines markedly with age. The decisive later finding was that its activity depends on chelated copper(II) — the peptide and the metal function as a unit. GHK-Cu is therefore a coordination complex, not simply a peptide, and it is the only such compound in this catalogue.
TB-500 (Thymosin Beta-4) — origin
TB-500 corresponds to the active region of Thymosin Beta-4, a 43-residue actin-sequestering protein present in virtually every mammalian cell type and abundant in wound fluid and platelets. Research interest followed the observation that the protein's activity in tissue-organisation models is largely retained by a short fragment of it.
GHK-Cu research themes
The best-populated area of the GHK-Cu literature, examined in dermal fibroblast models.
Studied for effects on the MMP/TIMP balance governing matrix turnover.
Copper itself is an angiogenic cofactor, and the complex is studied in that context.
Plasma GHK falls substantially between early and later adulthood, a finding central to research interest in the molecule.
TB-500 (Thymosin Beta-4) research themes
The defining studied mechanism: binding G-actin and influencing the polymerisation equilibrium that governs cell motility.
Investigated in models where directed cell movement into a tissue defect is the measured endpoint.
Two of the better-populated preclinical literatures for the parent protein.
Studied for effects on inflammatory signalling in tissue-injury models.
GHK-Cu handling
- Never reconstitute in acidic diluent — low pH dissociates the copper complex.
- Keep chelating agents such as EDTA out of any buffer used with this compound.
- Treat colour change as a discard signal: clear blue is correct, pale or green is not.
- Avoid contact with reducing agents, which will reduce Cu(II) to Cu(I) and collapse the complex.
TB-500 (Thymosin Beta-4) handling
- Minimise headspace exposure — each opening introduces oxygen that drives methionine oxidation.
- Keep reconstituted vials out of direct light, including bench lighting over long sessions.
- Introduce diluent against the vial wall; the cake is light and can be dispersed by a direct stream before it dissolves.
Both third-party tested
Every Popular Peptides batch of GHK-Cu and TB-500 (Thymosin Beta-4) is independently tested by HPLC and LC-MS with a published Certificate of Analysis. Enter a lot number to pull the COA for a specific vial.
GHK-Cu reference
Related comparisons
GHK-Cu and TB-500 (Thymosin Beta-4) are supplied strictly as research chemicals for in-vitro laboratory and research use only. They are not intended for human or animal consumption, diagnostic, or therapeutic use. This comparison summarizes published preclinical literature and laboratory handling data; it is not medical advice, not a claim of efficacy, and not usage guidance.